Health In Tech Reports Strong 71% Revenue Growth to $33.3M in 2025, Net Income Up 91%
Summary
Health In Tech reported strong financial results for 2025, with significant revenue and net income growth, driven by its AI-enabled platform and expanding customer base, alongside strategic executive appointments and equity plan expansion.
Key Events
-
Strong Revenue Growth in 2025
Total revenues increased by 71.0% to $33.3 million for the year ended December 31, 2025, up from $19.5 million in 2024.
-
Significant Net Income and Adjusted EBITDA Increase
Net income grew 90.7% to $1.28 million in 2025 from $0.67 million in 2024. Adjusted EBITDA also saw an 81.1% increase to $4.11 million from $2.27 million year-over-year.
-
Customer Base Expansion
The number of enrolled employees (EEs) increased by 23% to 22,515 as of December 31, 2025, reflecting strong market demand and channel expansion.
-
Equity Incentive Plan Expansion
The 2024 Equity Incentive Plan was amended to authorize an additional 3 million Class A common shares and include up to 2 million Class B common shares, potentially diluting existing shareholders but supporting future growth.
Analysis
Health In Tech, Inc. delivered robust financial results for fiscal year 2025, demonstrating significant growth across key metrics. The substantial increase in revenue, net income, and Adjusted EBITDA indicates strong operational performance and market penetration. The company's strategic focus on its AI-enabled platform, eDIYBS, is driving efficiency and customer expansion, as evidenced by the 23% growth in enrolled employees. While the expansion of the 2024 Equity Incentive Plan introduces potential dilution, it is positioned to support future growth initiatives and attract talent. The detailed disclosure on AI usage risks and the implementation of a governance policy reflect a proactive approach to managing emerging technological challenges. The appointment of several new C-suite executives further strengthens the management team for continued expansion.
At the time of this filing, HIT was trading at $1.62 on NASDAQ in the Finance sector, with a market capitalization of approximately $103M. The 52-week trading range was $0.51 to $4.02. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.